Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

NCT01723228 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Rasagiline
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.